FDA Inspection 1147027 — Zogenix, Inc.
The FDA completed an inspection of Zogenix, Inc. on July 15, 2021 in Emeryville, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 15, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Emeryville, CA (United States)
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)